Search

everythinglearnresearchcommunity

for

Search:↓

Latanoprost, a glaucoma medication, caused excessive eyelid hair growth in many patients.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Stopping oral contraceptives improved symptoms of porphyria cutanea tarda in a young woman.

Tripeptides help heal wounds and regenerate skin by speeding up tissue repair and reducing inflammation.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Self-assembling peptide hydrogels effectively deliver drugs locally, enhancing treatment and reducing side effects.

Targeting NETs may help reduce fibrosis in Crohn's disease.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.

Phellodendri Cortex Extract may help treat benign prostatic hyperplasia.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

The diphosphonate was the most effective at preventing calcification in rats.

Experts recommend using PN-HPT™ for skin rejuvenation in various body areas but have less agreement on initial facial treatment cycles.

CRF can cause hair loss, but blocking its receptors might prevent this.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Finasteride reduces opioid use and withdrawal symptoms in animals.

Hidradenitis suppurativa improves with antiandrogen therapy.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

Tridax procumbens shows potential for various health benefits but needs more scientific research.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Scientists identified three genes important for processing certain brain chemicals, thyroid hormones, and medications.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.